✦ LIBER ✦

Identification of the patients who respond safely and optimally to intervention with biologics; lesson learned from rheumatoid arthritis

✍ Scribed by Bay-Jensen, A.-C.; Siebuhr, A.; Byrjalsen, I.; Christiansen, C.; Karsdal, M.A.

Book ID: 122178310
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 94 KB
Volume: 21
Category: Article
ISSN: 1063-4584
DOI: 10.1016/j.joca.2013.02.083

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduction in the incidence of myocardial

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register

✍ W. G. Dixon; K. D. Watson; M. Lunt; K. L. Hyrich; A. J. Silman; D. P. M. Symmons 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

PMS79 Mixed Treatment Comparison of Biol

PMS79 Mixed Treatment Comparison of Biologic Agents in Patients with Rheumatoid Arthritis Who Have responded Inadequately to Methotrexate Therapy in the United Kingdom

✍ M. Lebmeier; L. Pericleous; P.C. Taylor; R. Christensen; P. Drost; G. Bergman; I 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Patients with early rheumatoid arthritis

Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts

✍ Saedis Saevarsdottir; Sara Wedrén; Maria Seddighzadeh; Camilla Bengtsson; Annmar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Correlation of C-reactive protein haplot

Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

✍ Darren Plant, Ibrahim Ibrahim, Mark Lunt, Stephen Eyre, Edward Flynn, Kimme L Hy 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 170 KB

Comparison of the response to infliximab

Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register

✍ Kimme L. Hyrich; Deborah P. M. Symmons; Kath D. Watson; Alan J. Silman; British 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 3 views

## Abstract ## Objective To compare outcome at 6 months in unselected “real‐world” patients with rheumatoid arthritis treated with etanercept or infliximab as either monotherapy, cotherapy with methotrexate (MTX), or cotherapy with another disease‐modifying antirheumatic drug (DMARD). ## Methods

Rapid and sustained improvement in bone

Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone

✍ Patrick Garnero; Elizabeth Thompson; Thasia Woodworth; Josef S. Smolen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 3 views

## Abstract ## Objective To investigate the effects of tocilizumab (TCZ) added to a stable dosage of methotrexate (MTX) on biochemical markers of bone and cartilage metabolism in patients in the multicenter double‐blind, placebo‐controlled OPTION (Tocilizumab Pivotal Trial in Methotrexate Inadequa